• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mLife . SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway

tetano

Editor, Senior Moderator
mLife

. 2026 Oct 26:10.1002/mlf2.70112.
doi: 10.1002/mlf2.70112. Online ahead of print.

SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway​


Lihong Liu 1 , Jie Du 2 , Jiacheng Huang 1 , Sidi Yang 1 , Qiaoqiao Xiao 3 , Liu Cao 2 , Hong Peng 2 , Birong Zheng 1 , Chunmei Li 2 , Deyin Guo 1 2

Affiliations Expand


Abstract​


The innate immune system functions as the frontline barrier against invading pathogens, such as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Nevertheless, the virus has developed various strategies to effectively regulate host immune responses, particularly through the inhibition of interferon signaling. In this study, we identify the SARS-CoV-2 accessory protein ORF6 as a key inhibitor of interferon gamma (IFNγ) signaling through downregulation of the interferon-induced 35-kDa protein (IFP35). IFP35, an interferon-stimulated gene (ISG) critical for interferon -mediated antiviral response, is significantly upregulated during SARS-CoV-2 infection. Silencing IFP35 via RNA interference enhances viral replication, indicating its antiviral role. Furthermore, we demonstrate that ORF6 associates with IFP35 and accelerates its ubiquitin-proteasome degradation, thereby impairing IFP35's ability to activate IFNγ signaling. These data reveal novel mechanisms used by SARS-CoV-2 to circumvent host immunity, specifically by impairing IFNγ signaling.

Keywords: IFNγ; IFP35; ORF6; SARS‐CoV‐2; type II interferon.
 
Back
Top Bottom